Quality improvement in neurology: muscular dystrophy quality measures

Pushpa Narayanaswami¹, Richard Dubinsky¹, David Wang¹+10

• ¹From Beth Israel Deaconess/Harvard Medical School (P.N.), Boston, MA; the University of Kansas (R.D.), Kansas City; Order of Saint Francis Health Care (D.W.), Peoria, IL; the American Academy of Neurology (G.G.), Minneapolis, MN; Massachusetts General Hospital/Harvard Medical School (W.D.), Boston, MA; The Children's Home of Pittsburgh (J.F.), PA; Mayo Clinic Scottsdale (B.S.), AZ; the Cleveland Clinic (J.C.), OH; Boston Children's Hospital/Harvard Medical School (F.S.); Neurology Foundation (M.M.), Cambridge, MA; Children's National Medical Center (C.S.), George Washington University, Washington, DC; the Muscular Dystrophy Association (J.W.), Tempe, AZ; and Louisiana State University (J.E.), New Orleans School of Medicine, LA.